DanielPKellyMD

Adult Congenital Heart Disease

Willard and Rhoda Ware Professor; Director, Cardiovascular Institute

Dr. Kelly is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3400 Civic Center Blvd
Smilow TRC 11-122
Philadelphia, PA 19104
Phone+1 215-898-0768

Washington University/B-JH/SLCH ConsortiumFellowship, Cardiovascular Disease, 1985 - 1988
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1982 - 1985
University of Illinois College of MedicineClass of 1982

PubMed

Cardiac NADdepletion in mice promotes hypertrophic cardiomyopathy and arrhythmias prior to impaired bioenergetics.
Khanh V Doan, Timothy S Luongo, Thato T Ts'olo, Won Dong Lee, David W Frederick
Nature Cardiovascular Research. 2024-10-01
3 citations
SGLT2 Inhibitors Act Independently of SGLT2 to Confer Benefit for HFrEF in Mice.
Justin H Berger, Timothy R Matsuura, Caitlyn E Bowman, Renee Taing, Jiten Patel
Circulation Research. 2024-08-16
Targeted Quantitative Plasma Metabolomics Identifies Metabolite Signatures that Distinguish Heart Failure with Reduced and Preserved Ejection Fraction.
Fawaz Naeem, Teresa C Leone, Christopher Petucci, Clarissa Shoffler, Ravindra C Kodihalli
Medrxiv. 2024-07-25

Children's Hospital of Philadelphia Receives $400,000 Grant from American Heart Association to Study Hormones Related to Cardiovascular Disease and Metabolic HealthAugust 4th, 2022
Failing Hearts Switch Fuels to Generate EnergyJanuary 26th, 2016
Differences Between “Marathon Mice” and “Couch Potato Mice” Reveal Key to Muscle FitnessFebruary 12th, 2016
Join now to see all